SPOTLIGHT: Medtronic to shed 1,100 jobs

Stalling sales of implantable defibrillators have prompted device maker Medtronic to cut 1,100 jobs; that's on top of 900 positions cut last year. The company employs nearly 40,000 total. Report | Report

Suggested Articles

Pfizer has scored FDA approval for its Humira biosimilar, but it can't launch the product for several years under a patent settlement.

The 3-2 vote on the deal was split along the party lines, spelling trouble for future biopharma M&A deals should Democrats move into the White House.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.